mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for KLK1
Gene summary
Basic gene Info.Gene symbolKLK1
Gene namekallikrein 1
SynonymsKLKR|Klk6|hK1
CytomapUCSC genome browser: 19q13.3
Type of geneprotein-coding
RefGenesNM_002257.3,
Descriptionglandular kallikrein 1kallikrein 1, renal/pancreas/salivarykallikrein serine protease 1kallikrein-1kidney/pancreas/salivary gland kallikreintissue kallikrein
Modification date20141207
dbXrefs MIM : 147910
HGNC : HGNC
Ensembl : ENSG00000167748
HPRD : 01003
Vega : OTTHUMG00000182876
ProteinUniProt: P06870
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_KLK1
BioGPS: 3816
PathwayNCI Pathway Interaction Database: KLK1
KEGG: KLK1
REACTOME: KLK1
Pathway Commons: KLK1
ContextiHOP: KLK1
ligand binding site mutation search in PubMed: KLK1
UCL Cancer Institute: KLK1
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for KLK1
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
K186K187QCOAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for KLK1
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
K186K187Q-0.48998754
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for KLK1 from PDB

Top
Differential gene expression and gene-gene network for KLK1
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of KLK1 and the right PPI network was created from samples without mutations in the LBS of KLK1. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for KLK1
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C0020538Hypertension20Biomarker, GeneticVariation, Therapeutic
umls:C0027051Myocardial Infarction6Biomarker, Therapeutic
umls:C0853897Diabetic Cardiomyopathies2Biomarker, Therapeutic
umls:C0011881Diabetic Nephropathies2Biomarker, Therapeutic
umls:C2609414Acute Kidney Injury1Therapeutic
umls:C0016059Fibrosis1Therapeutic

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for KLK1
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure
Approved|withdrawnDB06692AprotininBiotech

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of KLK1 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS


Top
Conservation information for LBS of KLK1
Multiple alignments for P06870 in multiple species
LBSAA sequence# speciesSpecies
H189KCIEAYEQKVT2Rattus norvegicus, Rattus norvegicus
H189ECKKAHVQKVT1Homo sapiens
H189KCIETYKDNVT1Rattus norvegicus
H189KCIETYKNIET1Rattus norvegicus
H189KCIKAHTQMVT1Rattus norvegicus
H189KCIKAYKEKVT1Rattus norvegicus
H189KCVEAHKEEVT1Rattus norvegicus
H189KCIKAYNDEVT1Rattus norvegicus
K186SNEKCIEAYEQ2Rattus norvegicus, Rattus norvegicus
K186PNDECKKAHVQ1Homo sapiens
K186SNEKCIETYKD1Rattus norvegicus
K186SNEKCIETYKN1Rattus norvegicus
K186SNEKCIKAHTQ1Rattus norvegicus
K186SNEKCIKAYKE1Rattus norvegicus
K186SNEKCVEAHKE1Rattus norvegicus
K186SNEKCIKAYND1Rattus norvegicus
V190CIEAYEQKVTD2Rattus norvegicus, Rattus norvegicus
V190CKKAHVQKVTD1Homo sapiens
V190CIETYKDNVTD1Rattus norvegicus
V190CIETYKNIETD1Rattus norvegicus
V190CIKAHTQMVTD1Rattus norvegicus
V190CIKAYKEKVTD1Rattus norvegicus
V190CVEAHKEEVTD1Rattus norvegicus
V190CIKAYNDEVTD1Rattus norvegicus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas